Correction to: Efficacy and Safety of ABP 798: Results from the JASMINE Trial in Patients with Follicular Lymphoma in Comparison with Rituximab Reference Product.

Journal

Targeted oncology
ISSN: 1776-260X
Titre abrégé: Target Oncol
Pays: France
ID NLM: 101270595

Informations de publication

Date de publication:
Dec 2020
Historique:
pubmed: 13 11 2020
medline: 13 11 2020
entrez: 12 11 2020
Statut: ppublish

Résumé

Page 608, 4 Discussion, right column, second paragraph.

Identifiants

DOI: 10.1007/s11523-020-00772-4 PMID: 33180232 PMC: PMC7701060
pubmed: 33180232
doi: 10.1007/s11523-020-00772-4
pii: 10.1007/s11523-020-00772-4
pmc: PMC7701060
doi:

Types de publication

Published Erratum

Langues

eng

Sous-ensembles de citation

IM

Pagination

807

Commentaires et corrections

Type : ErratumFor

Auteurs

Dietger Niederwieser (D)

Division of Hematology and Oncology, University of Leipzig, Liebigstr. 19, 04106, Leipzig, Germany. Dietger.Niederwieser@medizin.uni-leipzig.de.
Lithuanian University of Health Sciences, Kaunas, Lithuania. Dietger.Niederwieser@medizin.uni-leipzig.de.
School of Medicine, Aichi Medical University, Nagakute, Aichi/Nagoya, Japan. Dietger.Niederwieser@medizin.uni-leipzig.de.
ORCID: 0000-0002-4737-1103

Caroline Hamm (C)

Schulich School of Medicine, Western University, Windsor, ON, Canada.

Patrick Cobb (P)

St. Vincent Frontier Cancer Center, Billings, MT, USA.

Mindy Mo (M)

Amgen Inc., Thousand Oaks, CA, USA.

Cecily Forsyth (C)

Gosford Hospital, Gosford, NSW, Australia.

Alessandra Tucci (A)

Hematology Department, ASST-Spedali Civili-Brescia, Brescia, Italy.

Vladimir Hanes (V)

Amgen Inc., Thousand Oaks, CA, USA.

Vincent Delwail (V)

Oncology-Hematology and Cell Therapy, Centre Hospitalier Universitaire de Poitiers, Poitiers, France.

Roman Hajek (R)

Department of Hematooncology, Faculty of Medicine, University Hospital Ostrava, University of Ostrava, Ostrava, Czech Republic.

David Chien (D)

Amgen Inc., Thousand Oaks, CA, USA.

Classifications MeSH